Strategic Information for the Life Science and Analytical Instrument Industry
Clinical diagnostic testing has been a major bottleneck throughout the global response to the COVID-19 pandemic, with severe shortages of testing reagents, lack or slow adaptation of existing infrastructure to administer tests, and very rapidly growing demand that is outpacing supply. The extraordinary demand for COVID-19 testing has strained the production capabilities of vendors in […]
The development of cell and gene therapies has become an essential component of cancer and genetic disease research and treatment. Consequently, regulatory approvals for cell and gene therapy have begun to increase globally. As a result, cell and gene therapy research has expanded into other areas of medicine, such as treatments for autoimmune and dermatological diseases.
This is the third of IBO’s review of R&D investments related to COVID-19 (see March 27 and April 17). The outbreak has triggered a wide range of responses spanning immediate and long-term solutions. For R&D, spending priorities range from areas such as new diagnostic approaches and vaccine development to basic research in fields such as […]
The analytical and scientific instrument market in Europe is a compelling situation. According to IBO’s publisher Strategic Directions International (SDi) and part of Science and Medicine Group, prior to the COVID-19 pandemic, the industry’s recent performance in the region has been modest with periods of both enthusiastic and tepid demand. Despite the region’s strong presence […]
Test
Demand for analytical and scientific instrumentation has grown in Asia Pacific, excluding China and Japan (Asia Pacific). Specifically, these products have been utilized to address issues such as climate change and an aging population food production and new energy sources. Analytical and scientific instrumentation vendors have responded to the demands via distribution by local companies […]
Marking another new step forward in more effective COVID-19 testing, as of April 2, the US FDA had approved three molecular point-of-care (POC) tests for COVID-19. The POC assays enable testing in patient care settings such as doctors’ offices and urgent care facilities. POC tests are one of the urgently needed solutions to address the […]
Selected March 2020 COVID-19 Related R&D Funding Announcements Source Recipients Amount Details France National Research Agency and others €5 billion ($5 billion) The investment marks increase over 10 years to the country’s science budget. According to Reuters, 20% will go towards preparing for possible future epidemics. The funding encompasses €50 million ($54 million) in emergency […]
Cell line development (CLD) is often the crucial first step in a variety of applications from drug manufacturing to agricultural production, but current CLD processes are slow and laborious. Emeryville, California-based Berkeley Lights hopes to help researchers unleash innovation at a faster pace by shifting the traditional slow CLD workflow into higher gear. Earlier this […]
The coronavirus outbreak has led to the cancellation or postponement of many major scientific conferences planned for this spring. One conference that did take place was Pittcon 2020 (Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy). Held February 29 through March 5 in Chicago, Illinois, Pittcon 2020 took place before new advisories were issued, enabling […]
